We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Efficacy Study of Acupuncture to Treat Spinal Pain

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01909284
Recruitment Status : Unknown
Verified February 2014 by Un-Suk, Noh (PhD), Daegu Catholic University Medical Center.
Recruitment status was:  Recruiting
First Posted : July 26, 2013
Last Update Posted : February 4, 2014
Information provided by (Responsible Party):

Study Description
Brief Summary:
This study is being conducted to investigate the effectiveness and safety of acupuncture for alleviating pain of spondylosis.

Condition or disease Intervention/treatment
Low Back Pain Device: Acupuncture Procedure: Epidural nerve block

Detailed Description:

This study is being conducted at the Daegu Catholic University Medical Center. Enrolled participants will be randomized into two groups : acupuncture treatment plus epidural block and epidural block alone.

This trial will include treatments during 3 weeks, and then follow up after 2 weeks. Participants will have acupuncture treatments of three times per week and epidural block of once per week. All examinations and treatments will be provided free of charge. Compared with epidural block group, acupuncture plus epidural block group will give more effectiveness for alleviate pain caused by lumbar spondylosis.

Study Design

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 14 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Pilot Study of Efficacy and Safety of Acupuncture on Patient With Spinal Pain Due to Spondylolithesis
Study Start Date : March 2013
Estimated Primary Completion Date : March 2014
Estimated Study Completion Date : March 2014

Resource links provided by the National Library of Medicine

U.S. FDA Resources

Arms and Interventions

Arm Intervention/treatment
Experimental: Acupuncture & Epidural nerve block
acupuncture plus epidural block
Device: Acupuncture
  • BL40, BL60, ST36, GB34 : bilaterally, manual acupuncture.
  • Two points on 1st bladder meridian nearest location of back pain : bilaterally, electrical acupuncture.
Procedure: Epidural nerve block
Lumbar nerve block will be performed by using the mixture of dexamethasone (5mg) and mepivacaine (10mg).
Active Comparator: Epidural nerve block
epidural block alone
Procedure: Epidural nerve block
Lumbar nerve block will be performed by using the mixture of dexamethasone (5mg) and mepivacaine (10mg).

Outcome Measures

Primary Outcome Measures :
  1. Visual analogue scale(VAS) [ Time Frame: Change from baseline to 5 weeks ]
    This outcome will measure changes in the participant's level of low back pain.

Secondary Outcome Measures :
  1. Short form McGill pain questionnaire [ Time Frame: Chagnes from baseline to 5 weeks ]
  2. Oswestry Disability Index [ Time Frame: Changes from baseline to 5 weeks ]
  3. Present pain intensity(PPI) [ Time Frame: Changes from baseline to 5 weeks ]
  4. Pain vision [ Time Frame: Chagnes from baseline to 5 weeks ]
    A device Pain vision Ⓡ PS-2100 calculates a "degree of pain" in cancer patients in addition to VAS

Other Outcome Measures:
  1. Safety [ Time Frame: After the initiation of acupuncture, 2 weeks, and 4 weeks ]
    We will confirm the safety of acupuncture by determining the red blood cell (RBC) count, hemoglobin level, platelet count, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), hematocrit (Hct), total white blood cell (WBC) count, Erythrocyte Sedimentation Rate (ESR), aspartate aminotransferase (AST), alanine aminotransferase (ALT), serum urea nitrogen (BUN), creatinine level, serum sodium level, serum potassium level, and serum chloride level. All patients were evaluated 3 times, including a final follow-up visit 4 weeks after the initiation of acupuncture.

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   18 Years to 65 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Age 18 to 65 years
  • Meyerding Grade I-II spondylolisthesis
  • Low back pain of at least 1-year duration
  • Follow-up possible during the clinical trial
  • Written informed consent voluntarily

Exclusion Criteria:

  • Cauda equina syndrome, persistently exacerbated symptoms, progressive neurologic signs (sensory or motor changes)
  • Previous spine surgery
  • Senile dementia, impaired cognitive function or other cerebral disease, severe psychiatric or psychological disorders
  • Severe, concomitant disease (neuromuscular scoliosis, neurodegenerative disease)
  • All contraindications to corticosteroid injection (e.g., insulin-dependent diabetes)
  • Alcohol/drug abuse
  • Significant renal or hepatic disease
  • Pregnant, lactating or planning a pregnancy
  • Hypersensitive reaction to acupuncture treatment
  • Inability to comprehend or express oneself in the Korean language
  • An individual deemed to be ineligible by a physician
  • Refusal to participate in the trial or to provide informed consent
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01909284

Contact: Un-Suk Noh, M.D,Ph.D +82 53 650 4054 usno@cu.ac.kr

Korea, Republic of
Daegu Catholic University Medical Center Recruiting
Daegu, Kyungsangbukdo, Korea, Republic of
Sponsors and Collaborators
Daegu Catholic University Medical Center
Principal Investigator: Jeong-chul Seo, KMD, Ph.D. Comprehensive and Intergrative Medicine Institute
Principal Investigator: Min-Ah Gwak, KMD, Ph.D. Daegu Oriental Hospital of Daegu Haany University
Principal Investigator: Seong-Hoon Park, KMD Comprehensive and Integrative Medicine Insitute
More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Un-Suk, Noh (PhD), Department of anesthesiolgy, Daegu Catholic University Medical Center
ClinicalTrials.gov Identifier: NCT01909284     History of Changes
Other Study ID Numbers: CIMI-13-01-20
First Posted: July 26, 2013    Key Record Dates
Last Update Posted: February 4, 2014
Last Verified: February 2014

Additional relevant MeSH terms:
Back Pain
Low Back Pain
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms